| Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series KE Lunsford, M Javle, K Heyne, RT Shroff, R Abdel-Wahab, N Gupta, ... The lancet Gastroenterology & hepatology 3 (5), 337-348, 2018 | 226 | 2018 |
| Cholangiocarcinoma With FGFR Genetic Aberrations: A Unique Clinical Phenotype A Jain, MJ Borad, RK Kelley, Y Wang, R Abdel-Wahab, F Meric-Bernstam, ... JCO Precision Oncology 2, 1-12, 2018 | 177 | 2018 |
| Obesity early in adulthood increases risk but does not affect outcomes of hepatocellular carcinoma MM Hassan, R Abdel-Wahab, A Kaseb, A Shalaby, AT Phan, HB El-Serag, ... Gastroenterology 149 (1), 119-129, 2015 | 117 | 2015 |
| Estrogen replacement reduces risk and increases survival times of women with hepatocellular carcinoma MM Hassan, G Botrus, R Abdel-Wahab, RA Wolff, D Li, D Tweardy, ... Clinical Gastroenterology and Hepatology 15 (11), 1791-1799, 2017 | 108 | 2017 |
| Molecular profiling of hepatocellular carcinoma using circulating cell-free DNA AO Kaseb, NS Sánchez, S Sen, RK Kelley, B Tan, AG Bocobo, KH Lim, ... Clinical Cancer Research 25 (20), 6107-6118, 2019 | 76 | 2019 |
| Molecular spectrum of KRAS, NRAS, BRAF, PIK3CA, TP53, and APC somatic gene mutations in Arab patients with colorectal cancer: determination of frequency and distribution pattern HO Al-Shamsi, J Jones, Y Fahmawi, I Dahbour, A Tabash, ... Journal of gastrointestinal oncology 7 (6), 882, 2016 | 75 | 2016 |
| Intrahepatic cholangiocarcinoma: genomic heterogeneity between eastern and western patients J Cao, J Hu, S Liu, F Meric-Bernstam, R Abdel-Wahab, J Xu, Q Li, M Yan, ... JCO Precision Oncology 4, 557-569, 2020 | 64 | 2020 |
| Profiling of 3,634 cholangiocarcinomas (CCA) to identify genomic alterations (GA), tumor mutational burden (TMB), and genomic loss of heterozygosity (gLOH). MM Javle, K Murugesan, RT Shroff, MJ Borad, R Abdel-Wahab, ... Journal of Clinical Oncology 37 (15_suppl), 4087-4087, 2019 | 56 | 2019 |
| Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma AO Kaseb, M Hassan, S Lacin, R Abdel-Wahab, HM Amin, A Shalaby, ... Oncotarget 7 (43), 69916, 2016 | 50 | 2016 |
| Somatic genetic aberrations in gallbladder cancer: comparison between Chinese and US patients P Yang, M Javle, F Pang, W Zhao, R Abdel-Wahab, X Chen, ... Hepatobiliary surgery and nutrition 8 (6), 604, 2019 | 48 | 2019 |
| Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinoma R Abdel-Wahab, GR Varadhachary, PR Bhosale, X Wang, DR Fogelman, ... Journal of hematology & oncology 11, 1-9, 2018 | 41 | 2018 |
| Genomic profiling reveals high frequency of DNA repair genetic aberrations in gallbladder cancer R Abdel-Wahab, TA Yap, R Madison, S Pant, M Cooke, K Wang, H Zhao, ... Scientific reports 10 (1), 22087, 2020 | 36 | 2020 |
| Phase ii trial of bevacizumab and erlotinib as a second-line therapy for advanced hepatocellular carcinoma RAW Ahmed Omar Kaseb, Humaid Obaid Al-Shamsi, Jeffrey Morris, Michiko ... OncoTarget and Therapy 9, 733-780, 2016 | 35* | 2016 |
| Methodist–MD Anderson Joint Cholangiocarcinoma Collaborative Committee (MMAJCCC) KE Lunsford, M Javle, K Heyne, RT Shroff, R Abdel-Wahab, N Gupta, ... Liver transplantation for locally advanced intrahepatic cholangiocarcinoma …, 2018 | 25 | 2018 |
| Type i insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinoma RAW Ahmed O Kaseb, Samir Shehata, Manal M Hassan, Mouhammed A Habra ... j of hepatocellular carcinoma 2, 131-142, 2015 | 25* | 2015 |
| Clinical and prognostic significance of circulating levels of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinoma RC Pestana, MM Hassan, R Abdel-Wahab, YI Abugabal, LM Girard, D Li, ... Oncotarget 9 (102), 37721, 2018 | 21 | 2018 |
| Variations in DNA repair genomic alterations and tumor mutation burden in biliary tract cancer (BTC) subtypes. R Abdel-Wahab, SM Ali, MJ Borad, RT Shroff, L Kwong, JN Vauthey, ... Journal of Clinical Oncology 36 (4_suppl), 263-263, 2018 | 19 | 2018 |
| Yttrium-90 resin microspheres as an adjunct to sorafenib in patients with unresectable hepatocellular carcinoma A Mahvash, R Murthy, BC Odisio, KP Raghav, L Girard, S Cheung, ... Journal of hepatocellular carcinoma, 1-7, 2016 | 19 | 2016 |
| HepatoScore‐14: measures of biological heterogeneity significantly improve prediction of hepatocellular carcinoma risk JS Morris, MM Hassan, YE Zohner, Z Wang, L Xiao, A Rashid, A Haque, ... Hepatology 73 (6), 2278-2292, 2021 | 18 | 2021 |
| Refining prognosis in patients with hepatocellular carcinoma through incorporation of metabolic imaging biomarkers S Takeuchi, EM Rohren, R Abdel-Wahab, L Xiao, JS Morris, ... European journal of nuclear medicine and molecular imaging 44, 969-978, 2017 | 13 | 2017 |
Jeffrey S. MorrisUniversity of PennsylvaniaVerified email at pennmedicine.upenn.edu
